Bulk purchases— The Secretary of Health and Human Services (in this Act referred to as the “Secretary”) shall purchase in bulk a sufficient quantity of rapid tests for SARS–CoV–2 to provide two such tests per week to every resident of the United States over the 12-month period beginning on the date of enactment of this Act.
be made available together with a free postage-paid envelope for delivering completed tests to the Centers for Disease Control and Prevention or a relevant public health laboratory for genomic sequencing.
distribute to proctors of tests purchased pursuant to subsection (a) informational materials about social distancing, treatment, and further testing for individuals who test positive; and
Relation to Defense Production Act— In making purchases authorized under this section, the President may utilize the authorities provided under title I of the Defense Production Act of 1950 (50 U.S.C. 4511 et seq.).
Authorization of appropriations— To carry out this section, there are authorized to be appropriated such sums as may be necessary. The amounts authorized to be appropriated by the preceding sentence are in addition to amounts otherwise available to carry out this section.
Sec. 3
Coordination with Medicare and Medicaid programs
conduct outreach to individuals entitled to benefits under the Medicare or Medicaid programs regarding the availability of rapid tests (as defined in section 2); and
In general— Subject to paragraph (2), during the period of the public health emergency for COVID–19 in effect under section 319 of the Public Health Service Act (42 U.S.C. 247d), including any extensions thereof, an antigen diagnostic test for SARS–CoV–2 is deemed to have in effect an emergency use authorization under section 564 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–3) if the test is listed for emergency use by—
Continued authority— Upon the deeming of an emergency use authorization by paragraph (1) for a test, the Secretary of Health and Human Services and the Commissioner of Food and Drugs shall continue to have all authorities vested in such officials by the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and other applicable law to rescind such emergency use authorization or otherwise regulate such test.
Advisory committee on diagnostic and serological testing— The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall establish and maintain a permanent advisory committee to advise the Department of Health and Human Services regarding the development, manufacture, distribution, and use of diagnostic and serological testing for public health needs.